MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Racial and ethnic differences in patients with Parkinson’s Disease across Parkinson’s Disease Centers of Excellence

D. Di Luca, S. Luo, T. Davis, A. Ramirez-Zamora, M. Rafferty, N. Dahodwala, C. Marras (Toronto, Canada)
Randomised Controlled Trial Comparing Efficacy of Zonisamide 25 mg given in addition to standard treatment with standard treatment alone in Tremor dominant Parkinson’s Disease- A Pilot study.

K. Pillai, V. Goyal, A. Srivastava, R. Rajan, P. Srivastava, M. Singh, V. V.Y, D. Radhakrishnan, A. Elavarasi, P. Bhat (New Delhi, India)
Randomized, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of ABBV-0805, an Anti-Alpha-Synuclein Monoclonal Antibody in Healthy Subjects

H. Kalluri, C. Zadikoff, L. Rueter, O. Graff, H. Xiong (North Chicago, USA)
Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson’s disease

E. Cinar, G. Yalcin-Cakmakli, A. Ulusoy, E. Saka, B. Tel, B. Elibol (Zonguldak, Turkey)
Rapid blinking as an early clinical marker of Parkinson’s disease

M. Francis, T. Haque, D. Gallagher, C. Budu, A. Lee, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)
Rapid Onset Stiff Person Syndrome

B. Neeley, G. Pawar, R. Tripathi (Morgantown, USA)
Rapidly progressive dementia after MRI-guided Focused Ultrasound (MR-FUS)

JM. Perez Imbernon, S. Lopez Calvo, F. Castillo Alvarez, MT. Marti Sanchez, MM. Zambrano Vera, N. Reurich Gomez, ME. Marzo Sola (Logroño, Spain)
Rare Neurodegenerative Phenotypes in Patients Carrying Homozygous GBA1 Mutations

G. Lopez, N. Tayebi, M. Hallett, A. Zimran, P. Kishnani, E. Sidransky (Bethesda, USA)
Rare UQCRC1 variants in Chinese patients with Early Onset Parkinson’s Disease

XJ. Gu, YB. Hou, YP. Chen, RW. Ou, HF. Shang (Chengdu, China)
Re-thinking enrollment of Deep Brain Stimulation patients in Parkinson’s Disease Clinical Trials

J. Jimenez-Shahed, J. Rosenow, S. Miocinovic, L. Luo, C. Aquino, D. Corcos, P. Agarwal (New York, USA)
Real-world characteristics of advanced Parkinson’s disease patients initiating carbidopa/levodopa enteral suspension

M. Soileau, I. Malaty, J. Aldred, A. Merola, R. Rodriguez, N. Gupta, I. Sultan, P. Kandukuri, Y. Jalundhwala, O. Ladhani, I. Pan, R. Pahwa (Georgetown, USA)
Real-World Deep Brain Stimulation Outcomes Using Directional DBS Systems with Multiple Independent Current Control

C. Luca, T. Zesiewicz, M. Barbe, J. Volkmann, F. Clement, F. Ponce, C. Vander Linden, C. Zhao, M. Siddiqui, N. Tomycz, T. Prell, L. Chen, R. Jain (Miami, USA)
Real-World Evidence Supports use of Transcutaneous Afferent Patterned Stimulation for Tremor Control in Veteran’s Affairs Essential Tremor Patients

K. Colletta, S. Borucki, D. Fujikawa, C. Handforth, A. Phan, A. Killoran, A. Li, K. Rosenbluth (Hines, USA)
Real-World Outcomes Using a Novel Directional Lead from a Multicenter DBS Registry for Parkinson’s Disease

G. Deuschl, R. Jain, J. Wang, M. Barbe, S. Paschen, C. Sik Lee, J. Volkmann, A. Kühn, J. Vesper (Kiel, Germany)
Reanalysis of a Patient-Reported Outcome (Tardive Dyskinesia Impact Scale) Shows Positive Results

D. Stull, M. Bron, S. Bean, B. Williams, R. Farber, E. Franey, C. Yonan, R. Dhanda (New York, USA)
Reasons for refusing deep brain stimulation in patients with Parkinson’s disease: a retrospective 10-year study

E. Bril, A. Gamaleya, A. Tomskiy, A. Poddubskaia, N. Fedorova (Moscow, Russian Federation)
Recent advances in Physiotherapy management of Higher level Gait disorders among older adults: A narrative review of literature

T. Adeniji (Nguru, Nigeria)
Reduced Alpha suppression & altered EEG signal complexity in Parkinson’s disease – signatures of cognitive impairment?

S M. Keller, A. Meyer, U. Gschwandtner, S M. Beltrani, K. Toloraia, P. Fuhr (Basel, Switzerland)
Reduced cerebral energy metabolism in Parkinson’s disease in contrast to Progressive Supranuclear Palsy

J. Prasuhn, M. Göttlich, B. Ebeling, S. Kourou, F. Gerkan, C. Bodemann, S. Großer, K. Reuther, H. Hanssen, N. Brüggemann (Lübeck, Germany)
Reduced serum PRDX3 levels are a biomarker for Asian LRRK2 carriers in Parkinson’s disease

YJ. Tan, ZH. Lu, EYL. Ng, SYE. Ng, NSY. Chia, ACW. Yong, XY. Choi, DD. Heng, S. Neo, ZY. Xu, KY. Tay, WL. Au, LCS. Tan, EK. Tan, ASL. Ng (Singapore, Singapore)
Reducing anxiety improves freezing of gait in Parkinson’s disease patients

A. Al Jaja, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)
Regional brain iron and gene expression variation in Parkinson’s disease

G. Thomas, A. Zarkali, M. Ryten, K. Shmueli, AL. Gil Martinez, LA. Leyland, P. Mccolgan, J. Acosta-Cabronero, A. Lees, R. Weil (London, United Kingdom)
Registry Analysis (In Progress) to Evaluate Clinical Outcomes and Disease Burden of Advanced PD in Patients With Motor Fluctuations and Dyskinesia Managed With Oral Dopaminergic Therapies Versus Device-Aided Therapies

W. Hu, O. Ladhani, P. Kukreja, A. Ramirez-Zamora (Gainesville, USA)
RELATION BETWEEN COGNITIVE INHIBITORY CONTROL AND ANTICIPATORY POSTURAL ADJUSTMENT DURING A CONFLICTUAL STEP INITIATION TASK IN PARKINSON’S DISEASE INDIVIDUALS.

SM. Hondo, CN. de Oliveira, LS. de Oliveira, RC. Treza, MJ. Carvalho, AC. de Lima-Pardini, DB. Coelho (Sp, Brazil)
Relationship between frequency and severity of REM sleep behavior disorder and clinical features in patients with Parkinson’s disease

JY. Wang, Y. Shen, CF. Liu (Suzhou, China)
Relationship Between Hyposmia and Olfactory Network Connectivity in Patients With Parkinson’s Disease

L. Pesantez Pacheco, S. Horovitz (Bethesda, USA)
Relationship between low back pain-related disability and motor performance in people with Parkinson disease

R. Duncan, K. Rawson, T. Baker, J. Cavanaugh, C. Colon-Semenza, T. Deangelis, D. Fulford, M. Lavalley, T. Nordahl, M. Saint-Hillaire, C. Thomas, J. Zajac, T. Ellis, G. Earhart (Saint Louis, USA)
Relationship of satisfaction and adherence in remote digital monitoring: Results from a clinical drug trial in early Parkinson’s disease

B. Fehlmann, A. Thomann, W. Popp, F. Lipsmeier, E. Volkova-Volkmar, J. Friess, H. Svoboda, G. Pagano, T. Kilchemann, A. Bamdadian, W. Zago, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)
Relationship of subcortical iron deposition and mitochondrial dysfunction in patients with idiopathic Parkinson’s disease

J. Prasuhn, M. Göttlich, F. Gerkan, S. Kourou, B. Ebeling, M. Kasten, H. Hanssen, C. Klein, N. Brüggemann (Lübeck, Germany)
Reliability and Validity of the Greek Translation of the Scale for Assessment and Rating Ataxia in Ataxic Children

A. Lepoura, S. Lampropoulou, T. Schmitz-Hübsch, T. Panagopoulos, M. Papadopoulou, M. Pyrgeli, V. Papaevangelou, V. Sakellari (Egaleo, Greece)
REM sleep without atonia and nocturnal body position in prediagnostic Parkinson’s disease

F. Dijkstra, N. Reyn, B. de Bruyn, K. VAN.DEN Bossche, I. de Volder, M. Willemen, M. Viaene, J. Leenders, P. Cras, D. Crosiers (Edegem, Belgium)
Remote Art Therapy is feasible and may benefit individuals with Parkinson’s disease

J. Rieders, K. Astudillo, D. Mania, R. Kilachand, M. Berberian, I. Acosta, A. Cucca, A. Feigin (New York, USA)
Remote assessment of prodromal Parkinson’s disease in a LRRK2 G2019S cohort

J. Soto, S. Jensen-Roberts, T. Meyers, M. Pawlik, J. Moore, A. Sarkar, R. Wilson, P. Auinger, E. Dorsey, B. Valdovinos, K. Amodeo, S. Sharma, R. Holloway, H. Rowbotham, E. Chanoff, P. Cannon, R. Alcalay, R. Schneider (Rochester, USA)
Repeated gait perturbation training in healthy older adults and people with Parkinson’s disease. A systematic review and meta-analysis.

F. Hulzinga, V. de Rond, B. Vandendoorent, M. Gilat, P. Ginis, N. D'Cruz, C. Schlenstedt, A. Nieuwboer (Leuven, Belgium)
Reproductive factors and risk of Parkinson’s disease in women: preliminary results from the French prospective cohort E3N.

G. Pesce, F. Artaud, E. Roze, I. Degaey, A. Fournier, MC. Boutron-Ruault, A. Elbaz, M. Canonico (Villejuif, France)
RESPONDING TO COVID-19: THE “ALMEIDA-SANG EQUATION” TO PREDICT TOTAL DISEASE SEVERITY IN PARKINSON’S

K. Sangarapillai, B. Norman, Q. Almeida (Waterloo, Canada)
Resting state functional connectivity networks related to MDS-UPDRS motor outcomes in Parkinson’s Disease

A. Ragothaman, M. Mancini, J. Nutt, D. Fair, O. Miranda-Dominguez, F. Horak (Portland, USA)
Resting state functional MRI network assortativity is increased in Parkinson’s disease

A. Vo, K. Schindlbeck, N. Nguyen, A. Rommal, M. Niethammer, D. Eidelberg (Manhasset, USA)
Resting-state connectivity predictors for prefrontal cortex activity during walking in Parkinson’s disease.

H. Ding, I. Maidan, A. Droby, J. Hausdorff, A. Mirelman, S. Groppa, M. Muthuraman (Mainz, Germany)
Restless Leg Syndrome After Propranolol Intake: A Single Case

BC. Ari (Siirt, Turkey)
Restless leg syndrome and atherosclerosis: prospective study in the Canadian Longitudinal Study on Aging

S. Zolfaghari, K. Dasgupta, A. Pelletier, R. Postuma (Montreal, Canada)
Retrospective Review of Globus Pallidus Deep Brain Stimulation Electrode Contact Locations and Clinical Outcomes in Parkinson’s Disease

J. Jiao, M. Holland, A. Mitchell, D. Safarpour, K. Burchiel (Portland, USA)
Retrospective review of MRI-guided focused ultrasound (MRgFUS) thalamotomy referrals: updated experience from a single movement disorder center

E. Einstein, L. Pan, A. Mogilner (New York, USA)
Reversible hemichorea due to contralateral anterior cerebral artery territory hypoperfusion

S. Adukia, P. Shah, M. Shrivastava, G. Sangani, D. Sanghvi, M. Bhatt, A. Aggarwal (Mumbai, India)
Reversible MIBG Abnormalities in Subjects at Risk for Synucleinopathy: 12 months data

H. Maghzi, E. Hogg, E. Tan, G. Obiliasi, G. Pagano, M. Tagliati (Los Angeles, USA)
Review of intraoperative computed tomography accuracy for deep brain stimulation lead verification

Y. Willems, F. Steup, Z. Vallinga, C. Hoffmann, R. Zutt, M. Contarino, N. vd Gaag (The Hague, Netherlands)
Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles

E. Mcdonnell, Y. Wang, K. Marder (New York, USA)
RISK FACTORS FOR FALLS AMONG PEOPLE WITH PARKINSON ʼS DISEASE

T. Hernja Rumpf (Maribor, Slovenia)
Risk factors for the onset of dyskinesia in patients with Parkinson’s disease exhibiting wearing-off phenomena: A 1-year observational study in Japan (J-FIRST)

T. Mishima, SW. Chiu, H. Saiki, T. Yamaguchi, Y. Shimo, T. Maeda, H. Watanabe, K. Kashihara, M. Nomoto, N. Hattori, Y. Tsuboi (Fukuoka, Japan)
Risk of cancer in Parkinsons’s disease: a systematic review of diagnostic validity

A. Mehdiyeva, V. Kaasinen, J. Mauri, J. Sipilä (Joensuu, Finland)
Risk of Tardive Dyskinesia in Patients with Tic Disorders: Preliminary Results

M. Markota, B. Coombes, J. Leung, R. Savica (Rochester, USA)
RNA Editing in Parkinson’s Disease Shows Changes in Mitochondrial and Manganese-Binding Pathways in Multiple Brain Regions

A. Thele, O. Gardner, J. Vance, A. Griswold, J. Young, M. Pericak-Vance, W. Scott, E. Martin, W. Wang, D. Dykxhoorn, C. Petito, G. Beecham, D. Mash, S. Sivasankaran (Miami, USA)
Role of S100B in the Pathogenesis of Parkinson’s Disease

V. Balendra (Park Ridge, USA)
Role of Selective Serotonin Reuptake Inhibitors in the Management of Motor Tics in Tourette’s Syndrome

A. Armas-Salazar, J. Ortega-Márquez, D. Sandoval-Lopez, G. Pérez-Plascencia, C. Ortéga-Arenas, D. Chapa-Juárez (Ciudad de México, Mexico)
Role of the Stereotactic Dentatotomy for the management of Movement Disorders

A. Armas Salazar, JD. Carrillo Ruiz (Mexico City, Mexico)
Role of Uric Acid in Friedreich Ataxia neurodegeneration

A. Trinchillo, A. de Rosa, F. Saccà (Naples, Italy)

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z